BRAIN, SKELETAL MUSCLE AND PLATELET HOMOGENATE MITOCHONDRIAL FUNCTION IN PARKINSON'S DISEASE
Identifieur interne : 002595 ( Main/Exploration ); précédent : 002594; suivant : 002596BRAIN, SKELETAL MUSCLE AND PLATELET HOMOGENATE MITOCHONDRIAL FUNCTION IN PARKINSON'S DISEASE
Auteurs : V. M. Mann [Royaume-Uni] ; J. M. Cooper [Royaume-Uni] ; D. Krige [Royaume-Uni] ; S. E. Daniel [Royaume-Uni] ; A. H. V. Schapira [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]Source :
- Brain [ 0006-8950 ] ; 1992-04.
Abstract
The recent discovery of mitochondrial complex I deficiency in the substantia nigra of patients with idiopathic Parkinson's disease has provided new understanding into the possible mechanisms that may underlie this neurodegenerative disorder. The biochemical defect is identical to that induced in humans, primates and mice exposed to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. We have studied mitochondrial respiratory chain function in various brain regions, in skeletal muscle and in blood platelets from patients with idiopathic Parkinson's disease and from matched controls We provided evidence suggesting that the complex I deficency in Parkinson's disease is limited to the brain and that this defect is specific for the substantia nigra. The tissue specificity of the complex I deficiency in Parkinson's disease and its localization to the substantia nigra support the proposition that complex I deficiency may be directly involved in the cause of dopaminergic cell death in Parkinson's disease. An understanding of the molecular basis of this biochemical defect will provide valuable insight into the cause of Parkinson's disease. Our finding of normal mitochondnal function in platelet homogenates suggests that this tissue cannot be used to develop a ‘diagnostic test’ for Parkinson's disease.
Url:
DOI: 10.1093/brain/115.2.333
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>BRAIN, SKELETAL MUSCLE AND PLATELET HOMOGENATE MITOCHONDRIAL FUNCTION IN PARKINSON'S DISEASE</title><author><name sortKey="Mann, V M" sort="Mann, V M" uniqKey="Mann V" first="V. M." last="Mann">V. M. Mann</name></author><author><name sortKey="Cooper, J M" sort="Cooper, J M" uniqKey="Cooper J" first="J. M." last="Cooper">J. M. Cooper</name></author><author><name sortKey="Krige, D" sort="Krige, D" uniqKey="Krige D" first="D." last="Krige">D. Krige</name></author><author><name sortKey="Daniel, S E" sort="Daniel, S E" uniqKey="Daniel S" first="S. E." last="Daniel">S. E. Daniel</name></author><author><name sortKey="Schapira, A H V" sort="Schapira, A H V" uniqKey="Schapira A" first="A. H. V." last="Schapira">A. H. V. Schapira</name></author><author><name sortKey="Marsden, C D" sort="Marsden, C D" uniqKey="Marsden C" first="C. D." last="Marsden">C. D. Marsden</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:54C7AE4D8F61B835B72E42D3B892C9465F345275</idno><date when="1992" year="1992">1992</date><idno type="doi">10.1093/brain/115.2.333</idno><idno type="url">https://api.istex.fr/document/54C7AE4D8F61B835B72E42D3B892C9465F345275/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">002177</idno><idno type="wicri:Area/Main/Curation">001E68</idno><idno type="wicri:Area/Main/Exploration">002595</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">BRAIN, SKELETAL MUSCLE AND PLATELET HOMOGENATE MITOCHONDRIAL FUNCTION IN PARKINSON'S DISEASE</title><author><name sortKey="Mann, V M" sort="Mann, V M" uniqKey="Mann V" first="V. M." last="Mann">V. M. Mann</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Neuroscience, Royal Free Hospital School of Medicine London</wicri:regionArea><wicri:noRegion>Royal Free Hospital School of Medicine London</wicri:noRegion></affiliation></author><author><name sortKey="Cooper, J M" sort="Cooper, J M" uniqKey="Cooper J" first="J. M." last="Cooper">J. M. Cooper</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Neuroscience, Royal Free Hospital School of Medicine London</wicri:regionArea><wicri:noRegion>Royal Free Hospital School of Medicine London</wicri:noRegion></affiliation></author><author><name sortKey="Krige, D" sort="Krige, D" uniqKey="Krige D" first="D." last="Krige">D. Krige</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Neuroscience, Royal Free Hospital School of Medicine London</wicri:regionArea><wicri:noRegion>Royal Free Hospital School of Medicine London</wicri:noRegion></affiliation></author><author><name sortKey="Daniel, S E" sort="Daniel, S E" uniqKey="Daniel S" first="S. E." last="Daniel">S. E. Daniel</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Parkinson Disease Society Brain Bank London</wicri:regionArea></affiliation></author><author><name sortKey="Schapira, A H V" sort="Schapira, A H V" uniqKey="Schapira A" first="A. H. V." last="Schapira">A. H. V. Schapira</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Neuroscience, Royal Free Hospital School of Medicine London</wicri:regionArea><wicri:noRegion>Royal Free Hospital School of Medicine London</wicri:noRegion></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>University Department of Clinical Neurology, Institute of Neurology London</wicri:regionArea><wicri:noRegion>Institute of Neurology London</wicri:noRegion></affiliation></author><author><name sortKey="Marsden, C D" sort="Marsden, C D" uniqKey="Marsden C" first="C. D." last="Marsden">C. D. Marsden</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>University Department of Clinical Neurology, Institute of Neurology London</wicri:regionArea><wicri:noRegion>Institute of Neurology London</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Brain</title><idno type="ISSN">0006-8950</idno><idno type="eISSN">1460-2156</idno><imprint><publisher>Oxford University Press</publisher><date type="published" when="1992-04">1992-04</date><biblScope unit="volume">115</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="333">333</biblScope><biblScope unit="page" to="342">342</biblScope></imprint><idno type="ISSN">0006-8950</idno></series><idno type="istex">54C7AE4D8F61B835B72E42D3B892C9465F345275</idno><idno type="DOI">10.1093/brain/115.2.333</idno><idno type="ArticleID">115.2.333</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0006-8950</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract">The recent discovery of mitochondrial complex I deficiency in the substantia nigra of patients with idiopathic Parkinson's disease has provided new understanding into the possible mechanisms that may underlie this neurodegenerative disorder. The biochemical defect is identical to that induced in humans, primates and mice exposed to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. We have studied mitochondrial respiratory chain function in various brain regions, in skeletal muscle and in blood platelets from patients with idiopathic Parkinson's disease and from matched controls We provided evidence suggesting that the complex I deficency in Parkinson's disease is limited to the brain and that this defect is specific for the substantia nigra. The tissue specificity of the complex I deficiency in Parkinson's disease and its localization to the substantia nigra support the proposition that complex I deficiency may be directly involved in the cause of dopaminergic cell death in Parkinson's disease. An understanding of the molecular basis of this biochemical defect will provide valuable insight into the cause of Parkinson's disease. Our finding of normal mitochondnal function in platelet homogenates suggests that this tissue cannot be used to develop a ‘diagnostic test’ for Parkinson's disease.</div></front></TEI><affiliations><list><country><li>Royaume-Uni</li></country></list><tree><country name="Royaume-Uni"><noRegion><name sortKey="Mann, V M" sort="Mann, V M" uniqKey="Mann V" first="V. M." last="Mann">V. M. Mann</name></noRegion><name sortKey="Cooper, J M" sort="Cooper, J M" uniqKey="Cooper J" first="J. M." last="Cooper">J. M. Cooper</name><name sortKey="Daniel, S E" sort="Daniel, S E" uniqKey="Daniel S" first="S. E." last="Daniel">S. E. Daniel</name><name sortKey="Krige, D" sort="Krige, D" uniqKey="Krige D" first="D." last="Krige">D. Krige</name><name sortKey="Marsden, C D" sort="Marsden, C D" uniqKey="Marsden C" first="C. D." last="Marsden">C. D. Marsden</name><name sortKey="Schapira, A H V" sort="Schapira, A H V" uniqKey="Schapira A" first="A. H. V." last="Schapira">A. H. V. Schapira</name><name sortKey="Schapira, A H V" sort="Schapira, A H V" uniqKey="Schapira A" first="A. H. V." last="Schapira">A. H. V. Schapira</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002595 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002595 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:54C7AE4D8F61B835B72E42D3B892C9465F345275
|texte= BRAIN, SKELETAL MUSCLE AND PLATELET HOMOGENATE MITOCHONDRIAL FUNCTION IN PARKINSON'S DISEASE
}}
| This area was generated with Dilib version V0.6.23. |  |